Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin P Williams

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cancer Letters|October 3, 2017
Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cellsHelen O Oladapo, Michael Tarpley, Scott J Sauer, et al.
Redox Biology|September 30, 2023
Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasiaChorlada Paiboonrungruang, Zhaohui Xiong, David Lamson, et al.
Breast Cancer Research and Treatment|January 16, 2022
Racial differences in breast cancer outcomes by hepatocyte growth factor pathway expressionGieira S Jones, Katherine A Hoadley, Halei Benefield, et al.
The Journal of Clinical Investigation|August 20, 2003
Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivoHeather B Adkins, Caterina Bianco, Susan G Schiffer, et al.
Journal of Cancer|July 12, 2019
Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC ConsortiumGayathri R Devi, Holly Hough, Nadine Barrett, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cancer Letters|October 3, 2017
Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cellsHelen O Oladapo, Michael Tarpley, Scott J Sauer, et al.
Redox Biology|September 30, 2023
Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasiaChorlada Paiboonrungruang, Zhaohui Xiong, David Lamson, et al.
Breast Cancer Research and Treatment|January 16, 2022
Racial differences in breast cancer outcomes by hepatocyte growth factor pathway expressionGieira S Jones, Katherine A Hoadley, Halei Benefield, et al.
The Journal of Clinical Investigation|August 20, 2003
Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivoHeather B Adkins, Caterina Bianco, Susan G Schiffer, et al.
Journal of Cancer|July 12, 2019
Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC ConsortiumGayathri R Devi, Holly Hough, Nadine Barrett, et al.
Pageof 5